The table below provides the definition for this International Classification of Childhood Cancer (ICCC) variable. To see other variable definitions, see the ICCC home page.
Site Group | ICD-O-2 Histology (Type) | ICD-O-2 Site | Recode |
---|---|---|---|
I. Leukemia | |||
(a) Lymphoid Leukemia | |||
Acute lymphocytic leukemia (ALL) | 9821, 9828 | C000-C809 | 012 |
Lymphoid excluding ALL | 9820, 9822-9827, 9850 | C000-C809 | 011 |
(b) Acute non-lymphocytic leukemia | 9840, 9841, 9861, 9864, 9866, 9867, 9871-9874, 9891, 9894, 9910 | C000-C809 | 013 |
(c) Chronic myeloid leukemia | 9863, 9868 | C000-C809 | 015 |
(d) Other specified leukemia | 9830, 9842, 9860, 9862, 9870,9875-9890, 9892, 9893, 9900, 9930-9941 | C000-C809 | 016 |
(e) Unspecified leukemia | 9800-9804 | C000-C809 | 017 |
II. Lymphoma and reticuloendothelial neoplasms | |||
(a) Hodgkin lymphoma | 9650-9667 | C000-C809 | 021 |
(b) Non-Hodgkin lymphoma | 9591-9595, 9670-9686, 9688, 9690-9717, 9723 | C000-C809 | 022 |
(c) Burkitt lymphoma | 9687 | C000-C809 | 023 |
(d) Miscellaneous lymphoreticular neoplasms | 9720, 9731-9764 | C000-C809 | 024 |
(e) Unspecified lymphoma | 9590 | C000-C809 | 025 |
III. CNS and miscellaneous in tracranial and in traspinal neoplasms | |||
(a) Ependymoma | 9383, 9390-9394 | C000-C809 | 031 |
(b) As trocytoma | 9380 | C723 | 032 |
9381, 9400-9441 * | C000-C809 * | 032 | |
(c) Primitive neuroectodermal tumors | 9470-9473 * | C000-C809 * | 033 |
(d) Other gliomas | 9380 | C700-C722, C724-C729 | 034 |
9382, 9384 | C000-C809 | 034 | |
9442-9460, 9481 | C000-C809 | 034 | |
(e) Miscellaneous in tracranial and in traspinal neoplasms | 8270-8281, 8300, 9350-9362, 9480, 9505, 9530-9539 * | C000-C809 * | 035 |
(f) Unspecified in tracranial and in traspinal neoplasms | 8000-8004 | C700-C729, C751-C753 | 036 |
IV. Sympathetic nervous system tumors | |||
(a) Neuroblastoma and ganglioneuroblastoma | 9490, 9500 * | C000-C809 * | 041 |
(b) Other sympathetic nervous system tumors | 8680, 8693-8710, 9501-9504, 9520-9523 | C000-C809 | 042 |
V. Retinoblastoma | 9510-9512 | C000-C809 | 051 |
VI. Renal tumors | |||
(a) Wilms tumor, rhabdoid and clear cell sarcoma | 8963 | C649, C809 | 061 |
8960, 8964 | C000-C809 | 061 | |
(b) Renal carcinoma | 8010-8041, 8050-8075, 8082, 8120-8122, 8130-8141, 8143, 8155, 8190-8201, 8210, 8211, 8221-8231,8240, 8241, 8244-8246, 8260-8263, 8290, 8310, 8320, 8323, 8401, 8430, 8440, 8480-8490, 8504, 8510, 8550, 8560-8573 | C649 | 062 |
8312 | C000-C809 | 062 | |
(c) Unspecified malignant renal tumors | 8000-8004 | C649 | 063 |
VII. Hepatic tumors | |||
(a) Hepatoblastoma | 8970 | C000-C809 | 071 |
(b) Hepatic carcinoma | 8010-8041, 8050-8075, 8082, 8120-8122, 8140, 8141, 8143, 8155, 8190-8201, 8210, 8211, 8230, 8231,8240, 8241, 8244-8246, 8260-8263, 8310, 8320, 8323, 8401, 8430, 8440, 8480-8490, 8504, 8510, 8550, 8560-8573 | C220, C221 | 072 |
8160-8180 | C000-C809 | 072 | |
(c) Unspecified malignant hepatic tumors | 8000-8004 | C220, C221 | 073 |
VIII. Malignant bone tumors | |||
(a) Osteosarcoma | 9180-9200 | C000-C809 | 081 |
(b) Chrondosarcoma | 9220-9230 | C000-C809 | 082 |
9231, 9240 | C400-C419 | 082 | |
(c) Ewing sarcoma | 9260 | C400-C419, C809 | 083 |
9363, 9364 | C400-C419 | 083 | |
(d) Other specified malignant bone tumors | 8812, 9250, 9261-9330, 9370 | C000-C809 | 084 $ |
(e) Unspecified malignant bone tumors | 8000-8004, 8800, 8801, 8803, 8804 | C400-C419 | 085 $ |
IX. Soft-tissue sarcomas | |||
(a) Rhabdomyosarcoma and embryonal sarcoma | 8900-8920, 8991 | C000-C809 | 091 |
(b) Fibrosarcoma, neurofibrosarcoma and other fibromatous neoplasms | 8810, 8811, 8813-8833, 9540-9561 | C000-C809 | 092 |
(c) Kaposi sarcoma | 9140 | C000-C809 | 093 |
(d) Other specified soft-tissue sarcomas | 8840-8896, 8982, 8990, 9040-9044, 9120-9134, 9150-9170, 9251, 9581 | C000-C809 | 094 |
8963 | C000-C639, C659-C768 | 094 | |
9231, 9240, 9363, 9364 | C000-C399, C440-C809 | 094 | |
9260 | C000-C399, C470-C768 | 094 | |
(e) Unspecified soft-tissue sarcomas | 8800-8804 | C000-C399, C440-C809 | 095 |
X. Germ-cell, trophoblastic and other gonadal neoplasms | |||
(a) In tracranial and in traspinal germ-cell tumors | 9060-9102 | C700-C729, C751-C753 | 101 |
(b) Other and unspecified non-gonadal germ-cell tumors | 9060-9102 | C000-C559, C570-C619, C630-C699, C739-C750, C754-C809 | 102 |
(c) Gonadal germ-cell tumors | 9060-9102 | C569, C620-C629 | 103 |
(d) Gonadal carcinomas | 8010-8041, 8050-8075, 8120-8122, 8130-8141, 8143, 8155, 8190-8201, 8210, 8211, 8221-8241, 8244-8246, 8260-8263, 8290, 8310, 8320, 8323, 8430, 8440, 8480-8490, 8504, 8510, 8550, 8560-8573 | C569, C620-C629 | 104 |
8380, 8381, 8441-8473 | C000-C809 | 104 | |
(e) Other and unspecified malignant gonadal tumors | 8590-8670, 9000 | C000-C809 | 105 |
8000-8004 | C569, C620-C629 | 105 | |
XI. Carcinomas and other malignant epithelial neoplasms | |||
(a) Adrenocortical carcinoma | 8370-8375 | C000-C809 | 111 |
(b) Thyroid carcinoma | 8010-8041, 8050-8075, 8082, 8120-8122, 8130-8141, 8155, 8190, 8200, 8201, 8211, 8230, 8231, 8244-8246, 8260-8263, 8290, 8310, 8320, 8323, 8430, 8440, 8480, 8481, 8500-8573 | C739 | 112 |
8330-8350 | C000-C809 | 112 | |
(c) Nasopharyngeal carcinoma | 8010-8041, 8050-8075, 8082, 8120-8122, 8130-8141, 8155, 8190, 8200, 8201, 8211, 8230, 8231, 8244-8246, 8260-8263, 8290, 8310, 8320, 8323, 8430, 8440, 8480, 8481, 8504, 8510, 8550, 8560-8573 | C110-C119 | 113 |
(d) Malignant melanoma | 8720-8780 | C000-C809 | 114 |
(e) Skin carcinoma | 8010-8041, 8050-8075, 8082, 8090-8110, 8140, 8143, 8147, 8190, 8200, 8240, 8246, 8247, 8260, 8310, 8320, 8323, 8390-8420, 8430, 8480, 8542, 8560, 8570-8573, 8940 | C440-C449 | 115 |
(f) Other and unspecified carcinomas | 8010-8082, 8120-8155, 8190-8263, 8290, 8310, 8314-8323, 8430-8440, 8480-8580, 8940, 8941 | C000-C109, C129-C218, C239-C399, C480-C488, C500-C559, C570-C619, C630-C639, C659-C729, C750-C809 | 116 |
XII. Other and unspecified malignant neoplasms | |||
(a) Other specified malignant tumors | 8930, 8933, 8950, 8951, 8971-8981, 9020, 9050-9053, 9110, 9580 | C000-C809 | 121 |
(b) Other unspecified malignant tumors | 8000-8004 | C000-C218, C239-C399, C420-C559, C570-C619, C630-C639, C659-C699, C739-C750, C754-C809 | 122 |
Not classified by ICCC | 999 |
*ICD-O-2 histology and site definitions differ between IARC Technical Report No. 29 and the SEER modification.
$Recode value differs between IARC Technical Report No. 29 and the SEER modification.